TAMMARA BEZANSON: Open Payments
NPI 1598752586 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$786 in 36 payments from 19 companies in 2025. Trend: 2023 $535 · 2024 $726 · 2025 $786
Food & beverage: $786
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $138 |
| Corcept Therapeutics | 5 | $91 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $78 |
| Amgen Inc. | 2 | $62 |
| Antares Pharma, Inc. | 3 | $59 |
| Lilly USA, LLC | 2 | $40 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
| Sequel Med Tech, LLC | 2 | $36 |
| Averitas Pharma Inc. | 1 | $35 |
| Insulet Corporation | 1 | $32 |
Products named: SYNTHROID, Korlym, JARDIANCE, EVENITY, XYOSTED, UBRELVY, MOUNJARO, GVOKE HYPOPEN.
Industry payments across FL — which companies pay providers there.
